↓ Skip to main content

Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats

Overview of attention for article published in Cardiovascular Diabetology, November 2019
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
142 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats
Published in
Cardiovascular Diabetology, November 2019
DOI 10.1186/s12933-019-0964-4
Pubmed ID
Authors

Qingmiao Shao, Lei Meng, Sharen Lee, Gary Tse, Mengqi Gong, Zhiwei Zhang, Jichao Zhao, Yungang Zhao, Guangping Li, Tong Liu

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 142 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 142 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 17 12%
Student > Bachelor 12 8%
Student > Ph. D. Student 10 7%
Student > Master 10 7%
Student > Doctoral Student 7 5%
Other 26 18%
Unknown 60 42%
Readers by discipline Count As %
Medicine and Dentistry 35 25%
Agricultural and Biological Sciences 8 6%
Biochemistry, Genetics and Molecular Biology 8 6%
Pharmacology, Toxicology and Pharmaceutical Science 8 6%
Nursing and Health Professions 4 3%
Other 13 9%
Unknown 66 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 November 2019.
All research outputs
#20,592,137
of 23,177,498 outputs
Outputs from Cardiovascular Diabetology
#1,249
of 1,414 outputs
Outputs of similar age
#384,422
of 459,050 outputs
Outputs of similar age from Cardiovascular Diabetology
#32
of 36 outputs
Altmetric has tracked 23,177,498 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,414 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.1. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 459,050 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 36 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.